Yonhap Infomax NewsFeb 2
Chong Kun Dang, a major South Korean pharmaceutical firm, saw its 2023 operating profit fall 19% as rising SG&A and R&D costs, along with a negative base effect, offset revenue growth.
#YonhapInfomax #ChongKunDang #OperatingProfit #SGAExpenses #RDCosts #2023Earnings #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103357
Chong Kun Dang Reports 19% Decline in 2023 Operating Profit—'Higher SG&A and R&D Expenses Drive Negative Base Effect'

Chong Kun Dang, a major South Korean pharmaceutical firm, saw its 2023 operating profit fall 19% as rising SG&A and R&D costs, along with a negative base effect, offset revenue growth.

Yonhap Infomax
Yonhap Infomax NewsNov 3
Chong Kun Dang Pharmaceutical posted a 19% drop in Q3 operating profit despite higher sales, as drug price cuts and increased R&D spending weighed on margins.
#YonhapInfomax #ChongKunDang #OperatingProfit #Q3Earnings #DrugPriceCuts #RDCosts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88881
Chong Kun Dang Reports Q3 Operating Profit of 20.5 Billion Won, Down 18.7% Year-on-Year (Update)

Chong Kun Dang Pharmaceutical posted a 19% drop in Q3 operating profit despite higher sales, as drug price cuts and increased R&D spending weighed on margins.

Yonhap Infomax
Yonhap Infomax NewsJul 10, 2025
Morgan Stanley forecasts that the Trump administration’s tax reform will significantly boost profits for major US tech firms, with Microsoft, Oracle, and others set to benefit from favorable R&D expense rules.
#YonhapInfomax #MorganStanley #TrumpTaxCuts #Microsoft #RDCosts #FreeCashFlowMargin #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=71544
Morgan Stanley Says Trump Tax Cuts to Boost Big Tech Profits—Microsoft, Oracle Among Beneficiaries

Morgan Stanley forecasts that the Trump administration’s tax reform will significantly boost profits for major US tech firms, with Microsoft, Oracle, and others set to benefit from favorable R&D expense rules.

Yonhap Infomax